KR920012107A - 3'-(2')-아미노- 또는 티올-변형되고 형광 염료-결합된 뉴클레오사이드, 뉴클레오타이드 및 올리고뉴클레오타이드, 및 이의 제조방법 및 용도 - Google Patents
3'-(2')-아미노- 또는 티올-변형되고 형광 염료-결합된 뉴클레오사이드, 뉴클레오타이드 및 올리고뉴클레오타이드, 및 이의 제조방법 및 용도 Download PDFInfo
- Publication number
- KR920012107A KR920012107A KR1019910022614A KR910022614A KR920012107A KR 920012107 A KR920012107 A KR 920012107A KR 1019910022614 A KR1019910022614 A KR 1019910022614A KR 910022614 A KR910022614 A KR 910022614A KR 920012107 A KR920012107 A KR 920012107A
- Authority
- KR
- South Korea
- Prior art keywords
- amino
- group
- compound
- oligonucleotides
- thiol
- Prior art date
Links
- 108091034117 Oligonucleotide Proteins 0.000 title claims 5
- 239000007850 fluorescent dye Substances 0.000 title claims 5
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title claims 4
- 125000003835 nucleoside group Chemical group 0.000 title claims 4
- 239000002773 nucleotide Substances 0.000 title claims 4
- 125000003729 nucleotide group Chemical group 0.000 title claims 4
- 238000000034 method Methods 0.000 title claims 3
- 239000002777 nucleoside Substances 0.000 title claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 5
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 4
- 230000015572 biosynthetic process Effects 0.000 claims 3
- -1 fluoro Methylene, difluoromethylene Chemical group 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 3
- 238000003786 synthesis reaction Methods 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 150000001540 azides Chemical class 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims 1
- 235000011180 diphosphates Nutrition 0.000 claims 1
- ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 claims 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims 1
- 238000001917 fluorescence detection Methods 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 claims 1
- 230000000269 nucleophilic effect Effects 0.000 claims 1
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 235000021317 phosphate Nutrition 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- IGFXRKMLLMBKSA-UHFFFAOYSA-N purine Chemical compound N1=C[N]C2=NC=NC2=C1 IGFXRKMLLMBKSA-UHFFFAOYSA-N 0.000 claims 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 claims 1
- 235000011178 triphosphate Nutrition 0.000 claims 1
- 239000001226 triphosphate Substances 0.000 claims 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (6)
- 일반식(I)와 3′-및/또는 2′-아미노- 및 티올-변형된 뉴클레오사이드, 뉴클레오타이드 또는 올리고뉴클레오타이드.상기 식에서, R1은 퓨린 또는 피리미딘 염기이고, 라디칼 R2및 R3중 적어도 하나는 아미노 또는 티올 그룹을 통해 결합되는 α 또는 β위치에 존재하는 형광 염료이고, 다른 라디칼은 α 또는 β위치에 존재하는 임의의 수소, 하이드록실, 보호된 하이드록실 또는 메톡시 그룹이며, n은 0 이상의 수이고, R4는 5′ 보호그룹 또는 포스페이트, 피로포스페이트, 트리포스페이트이며, R5는 산소, 플루오로메틸렌, 디플루오로메틸렌 또는 메틸렌이고, R6는 α 또는 β위치에 존재하는 하이드록실 또는 메톡시 그룹 또는 수소(이때, R1, R5및 R6는 각각의 경우에 동일하거나 상이할 수 있다)이며, X 및 Y는 산소, 황, NH 또는 메틸렌(이때, X 및 Y는 각각의 경우에 동일하거나 상이할 수 있다)이다.
- 뉴클레오사이드, 뉴클레오타이드 또는 올리고뉴클레오타이드의 3′및/또는 2′위치에 존재하는 OH그룹을 아미노 또는 티올 그룹으로 유도체화시킨 후 형광 염료상에 결합시킴을 특징으로 하여, 제1항에 따른 일반식(I)의 화합물을 제조하는 방법.
- (a) 일반식(II)의 화합물에 친핵성 공격에 의해 3′ 및/또는 2′ 위치에 보호되거나 보호되지 않는 상태의 아지드 또는 티올을 도입시키고, 필요한 경우 아지드를 아민으로 환원시키고, (b) 아미노 그룹 또는 티올 그룹을 통해 형광 염료를 결합시킴을 특징으로 하여, 일반식(I)의 화합물을 제조하는 방법.상기 식에서, R1내지 R6, X, Y 및 n은 제1항에서 정의한 바와 같고, R1, R5및 R6는 각각의 경우에서 동일하거나 상이한 의미를 가지며, R7및 R8은 수소, 하이드록실 또는 보호된 하이드록실 또는 메톡시 그룹이다.
- 제3항에 있어서, 형광 염료로서 플루오레세인, 로다민, 텍사스 레드(Texas red), NBD, 코우마린, 플루오레스카민, 숙시닐 플루오레세인 및 단실을 사용하는 방법.
- (a) DAN 및 RNA 뉴클레오사이드, 뉴클레오타이드 및 올리뉴클레오타이드의 합성, 및 (b) 생체내 및 시험관내에서 현미경적 및 육안적 형광검출을 위한 제1항에 따른 일반식(I)의 화합물의 용도.
- 제5항에 있어서, 일반식(I)의 화합물의 (a)주형 본쇄의 존재하에서 상보적 본쇄의 합성, 및 (b) 올리고뉴클레오타이드의 합성을 위한 용도.※ 참고사항: 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4039488 | 1990-12-11 | ||
DEP4039488.3 | 1990-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR920012107A true KR920012107A (ko) | 1992-07-25 |
Family
ID=6420050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019910022614A KR920012107A (ko) | 1990-12-11 | 1991-12-11 | 3'-(2')-아미노- 또는 티올-변형되고 형광 염료-결합된 뉴클레오사이드, 뉴클레오타이드 및 올리고뉴클레오타이드, 및 이의 제조방법 및 용도 |
Country Status (27)
Country | Link |
---|---|
US (3) | US5679785A (ko) |
EP (1) | EP0490281B1 (ko) |
JP (1) | JP3140127B2 (ko) |
KR (1) | KR920012107A (ko) |
AT (1) | ATE142222T1 (ko) |
AU (1) | AU643856B2 (ko) |
BG (1) | BG61484B1 (ko) |
BR (1) | BR9105335A (ko) |
CA (1) | CA2057475A1 (ko) |
CS (1) | CS374391A3 (ko) |
DE (1) | DE59108143D1 (ko) |
DK (1) | DK0490281T3 (ko) |
ES (1) | ES2093671T3 (ko) |
FI (1) | FI915779A (ko) |
GR (1) | GR3021041T3 (ko) |
HU (1) | HUT60505A (ko) |
IE (1) | IE75726B1 (ko) |
IL (1) | IL100298A (ko) |
MX (1) | MX9102468A (ko) |
NO (1) | NO914859L (ko) |
NZ (1) | NZ240900A (ko) |
PL (1) | PL168874B1 (ko) |
PT (1) | PT99747A (ko) |
RO (1) | RO111575B1 (ko) |
RU (1) | RU2073682C1 (ko) |
TR (1) | TR27715A (ko) |
YU (1) | YU187991A (ko) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5476925A (en) * | 1993-02-01 | 1995-12-19 | Northwestern University | Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups |
US5599922A (en) * | 1994-03-18 | 1997-02-04 | Lynx Therapeutics, Inc. | Oligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance properties |
CA2184375C (en) * | 1994-03-18 | 2006-05-02 | Sergei M. Gryaznov | Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties |
US5726297A (en) * | 1994-03-18 | 1998-03-10 | Lynx Therapeutics, Inc. | Oligodeoxyribonucleotide N3' P5' phosphoramidates |
DE4418691A1 (de) * | 1994-05-28 | 1996-02-22 | Boehringer Mannheim Gmbh | 3'-(4'-) nicht-radioaktiv markierte Nukleoside und Nukleotide mit Aminocarbonsäure-, Peptid- oder Carbonsäure-Spacer |
US5962271A (en) * | 1996-01-03 | 1999-10-05 | Cloutech Laboratories, Inc. | Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end |
US5859233A (en) * | 1996-02-21 | 1999-01-12 | Lynx Therapeutics, Inc. | Synthons for synthesis of oligonucleotide N3-P5 phosphoramidates |
US5684143A (en) * | 1996-02-21 | 1997-11-04 | Lynx Therapeutics, Inc. | Oligo-2'-fluoronucleotide N3'->P5' phosphoramidates |
US6017702A (en) * | 1996-12-05 | 2000-01-25 | The Perkin-Elmer Corporation | Chain-termination type nucleic acid sequencing method including 2'-deoxyuridine-5'-triphosphate |
DE19741084A1 (de) * | 1997-09-18 | 1999-03-25 | Knoell Hans Forschung Ev | Hochaffine Nukleinsäuremoleküle mit funktionellen Gruppen zur spezifischen Erkennung von Zielmolekülen, ihre Herstellung und Verwendung |
US6289229B1 (en) | 1998-01-20 | 2001-09-11 | Scimed Life Systems, Inc. | Readable probe array for in vivo use |
US6184347B1 (en) | 1998-11-19 | 2001-02-06 | Agilent Technologies Inc. | Minimization of blooming in high-density arrays by using reactive wash reagents |
US6761877B2 (en) * | 2000-02-18 | 2004-07-13 | Biocrystal, Ltd. | Functionalized encapsulated fluorescent nanocrystals |
ATE352586T2 (de) * | 2000-09-29 | 2007-02-15 | Molecular Probes Inc | Modifizierte carbocyaninfarbstoffe und deren konjugate |
US7563618B2 (en) | 2001-03-23 | 2009-07-21 | Geron Corporation | Oligonucleotide conjugates |
KR100762261B1 (ko) | 2001-04-27 | 2007-10-04 | (주)바이오니아 | 전장 상보 디옥시리보핵산 제조 방법과 이에 사용되는앵커와 프라이머 |
US7214428B2 (en) * | 2001-09-17 | 2007-05-08 | Invitrogen Corporation | Highly luminescent functionalized semiconductor nanocrystals for biological and physical applications |
US7205048B2 (en) | 2001-09-17 | 2007-04-17 | Invitrogen Corporation | Functionalized fluorescent nanocrystal compositions and methods of making |
WO2003054507A2 (en) * | 2001-09-17 | 2003-07-03 | Biocrystal, Ltd. | Nanocrystals |
WO2004055160A2 (en) * | 2002-12-13 | 2004-07-01 | The Trustees Of Columbia University In The City Of New York | Biomolecular coupling methods using 1,3-dipolar cycloaddition chemistry |
JP4177123B2 (ja) * | 2003-01-10 | 2008-11-05 | 富士通株式会社 | 配線図形検証方法、プログラム及び装置 |
KR100890885B1 (ko) | 2003-03-31 | 2009-03-31 | 에프. 호프만-라 로슈 아게 | 일본 뇌염 바이러스 혈청군의 구성원을 포함하는, 특정플라비바이러스 검출용 조성물 및 방법 |
US20050131224A1 (en) * | 2003-12-15 | 2005-06-16 | Cti Pet Systems, Inc. | Method for preparing radiolabeled thymidine |
US7160537B2 (en) * | 2003-12-15 | 2007-01-09 | Siemens Medical Solutions Usa, Inc. | Method for preparing radiolabeled thymidine having low chromophoric byproducts |
US7939251B2 (en) | 2004-05-06 | 2011-05-10 | Roche Molecular Systems, Inc. | SENP1 as a marker for cancer |
WO2006033732A1 (en) * | 2004-08-17 | 2006-03-30 | Invitrogen Corporation | Synthesis of highly luminescent colloidal particles |
US7368086B2 (en) * | 2004-10-29 | 2008-05-06 | Invitrogen Corporation | Functionalized fluorescent nanocrystals, and methods for their preparation and use |
US20090118132A1 (en) * | 2004-11-04 | 2009-05-07 | Roche Molecular Systems, Inc. | Classification of Acute Myeloid Leukemia |
US7541144B2 (en) * | 2005-01-31 | 2009-06-02 | Agilent Technologies, Inc. | RNA labeling method |
EP2233581A1 (en) | 2005-02-01 | 2010-09-29 | AB Advanced Genetic Analysis Corporation | Nucleic acid sequencing by performing successive cycles of duplex extension |
US7544471B2 (en) * | 2005-07-30 | 2009-06-09 | Agilent Technologies, Inc. | Preparing RNA from a wax-embedded tissue specimen |
US7700289B2 (en) * | 2006-04-03 | 2010-04-20 | Agilent Technologies, Inc. | Method for labeling RNA |
CA2649725A1 (en) * | 2006-04-19 | 2007-10-25 | Applera Corporation | Reagents, methods, and libraries for gel-free bead-based sequencing |
US7572585B2 (en) * | 2006-07-31 | 2009-08-11 | Agilent Technologies, Inc. | Enzymatic labeling of RNA |
BRPI0719923B1 (pt) * | 2006-12-05 | 2021-08-17 | Agilent Technologies Inc | Métodos para sequenciamento de um ácido nucléico alvo, para conversão de um componente de ocorrência não natural em uma molécula de ácido nucléico em um componente de ocorrência natural, para terminar uma síntese de ácido nucléico, e para realizar o sequenciamento de sanger ou tipo sanger, e compostos |
AU2008283902B2 (en) | 2007-08-06 | 2014-03-13 | Orion Genomics Llc | Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene |
JP2009077712A (ja) | 2007-09-11 | 2009-04-16 | F Hoffmann La Roche Ag | B−Rafキナーゼ阻害剤に対する感受性についての診断試験 |
US20090191553A1 (en) * | 2007-10-01 | 2009-07-30 | Applied Biosystems Inc. | Chase Ligation Sequencing |
US20100086914A1 (en) * | 2008-10-03 | 2010-04-08 | Roche Molecular Systems, Inc. | High resolution, high throughput hla genotyping by clonal sequencing |
EP2955234A1 (en) | 2009-02-11 | 2015-12-16 | Orion Genomics, LLC | Combinations of polymorphisms for determining allele-specific expression of igf2 |
US8431416B2 (en) | 2009-04-01 | 2013-04-30 | Becton, Dickinson And Company | Reactive heterocycle-substituted 7-hydroxycoumarins and their conjugates |
EP2473563B1 (en) * | 2009-08-31 | 2019-06-19 | Promega Corporation | Reactive cyanine compounds |
WO2011128096A1 (en) | 2010-04-16 | 2011-10-20 | Roche Diagnostics Gmbh | Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment |
PL2576837T3 (pl) | 2010-06-04 | 2018-04-30 | Chronix Biomedical | Krążeniowe biomarkery typu kwasu nukleinowego związane z rakiem prostaty |
US8623324B2 (en) | 2010-07-21 | 2014-01-07 | Aat Bioquest Inc. | Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates |
EP2768985B1 (en) | 2011-10-21 | 2019-03-20 | Chronix Biomedical | Colorectal cancer associated circulating nucleic acid biomarkers |
ES2413566B1 (es) | 2011-12-14 | 2014-05-20 | Fundación Pública Andaluza Progreso Y Salud | Método de obtención de datos útiles para el diagnóstico y pronóstico de la hipoacusia neurosensorial. |
US9957549B2 (en) | 2012-06-18 | 2018-05-01 | Nugen Technologies, Inc. | Compositions and methods for negative selection of non-desired nucleic acid sequences |
ES2703764T3 (es) | 2012-12-14 | 2019-03-12 | Chronix Biomedical | Biomarcadores personalizados para el cáncer |
SI3004388T2 (sl) | 2013-05-29 | 2023-11-30 | Chronix Biomedical | Odkrivanje in kvantifikacija donorjeve brezcelične DNK v cirkulaciji prejemnikov presajenih organov |
DK3201361T3 (da) | 2014-10-01 | 2020-05-18 | Chronix Biomedical | Fremgangsmåder til kvantificering af cellefrit DNA |
JP2019512573A (ja) | 2016-03-28 | 2019-05-16 | エーエーティー バイオクエスト インコーポレイテッド | ポリフルオレノ[4,5−cde]オキセピンコンジュゲート及び分析物検出方法におけるそれらの使用 |
US11220628B2 (en) | 2019-02-20 | 2022-01-11 | Aat Bioquest, Inc. | Condensed polycyclic conjugated polymers and their use for biological detection |
EP4097477A1 (en) | 2020-01-30 | 2022-12-07 | Aat Bioquest, Inc. | Uv excitable polyfluorene based conjugates and their use in methods of analyte detection |
WO2023147355A2 (en) * | 2022-01-25 | 2023-08-03 | Oregon Health & Science University | Methods and systems for increasing capture potential of a spatial array |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4849513A (en) * | 1983-12-20 | 1989-07-18 | California Institute Of Technology | Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups |
US5015733A (en) * | 1983-12-20 | 1991-05-14 | California Institute Of Technology | Nucleosides possessing blocked aliphatic amino groups |
EP0267996A1 (en) * | 1986-11-20 | 1988-05-25 | Tamir Biotechnology Ltd. | New nucleotide derivatives |
GB2236852B (en) * | 1989-09-25 | 1994-04-06 | Scotgen Ltd | DNA probe based assays and intermediates useful in the synthesis of cleavable nucleic acids for use in such assays |
US5227487A (en) * | 1990-04-16 | 1993-07-13 | Molecular Probes, Inc. | Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes |
US5541307A (en) * | 1990-07-27 | 1996-07-30 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs and solid phase synthesis thereof |
-
1991
- 1991-12-02 YU YU187991A patent/YU187991A/sh unknown
- 1991-12-04 BG BG95575A patent/BG61484B1/bg unknown
- 1991-12-06 DK DK91120935.1T patent/DK0490281T3/da active
- 1991-12-06 ES ES91120935T patent/ES2093671T3/es not_active Expired - Lifetime
- 1991-12-06 DE DE59108143T patent/DE59108143D1/de not_active Expired - Fee Related
- 1991-12-06 EP EP91120935A patent/EP0490281B1/de not_active Expired - Lifetime
- 1991-12-06 AT AT91120935T patent/ATE142222T1/de not_active IP Right Cessation
- 1991-12-09 TR TR01195/91A patent/TR27715A/xx unknown
- 1991-12-09 IL IL100298A patent/IL100298A/xx not_active IP Right Cessation
- 1991-12-09 RO RO148926A patent/RO111575B1/ro unknown
- 1991-12-09 FI FI915779A patent/FI915779A/fi unknown
- 1991-12-09 NZ NZ24090091A patent/NZ240900A/en unknown
- 1991-12-10 CA CA002057475A patent/CA2057475A1/en not_active Abandoned
- 1991-12-10 MX MX9102468A patent/MX9102468A/es unknown
- 1991-12-10 IE IE430191A patent/IE75726B1/en not_active IP Right Cessation
- 1991-12-10 PT PT99747A patent/PT99747A/pt not_active Application Discontinuation
- 1991-12-10 AU AU88927/91A patent/AU643856B2/en not_active Ceased
- 1991-12-10 NO NO91914859A patent/NO914859L/no unknown
- 1991-12-10 HU HU913885A patent/HUT60505A/hu unknown
- 1991-12-10 CS CS913743A patent/CS374391A3/cs unknown
- 1991-12-10 RU SU915010267A patent/RU2073682C1/ru active
- 1991-12-10 PL PL91292701A patent/PL168874B1/pl unknown
- 1991-12-11 KR KR1019910022614A patent/KR920012107A/ko not_active Application Discontinuation
- 1991-12-11 BR BR919105335A patent/BR9105335A/pt unknown
- 1991-12-11 JP JP03350821A patent/JP3140127B2/ja not_active Expired - Fee Related
-
1994
- 1994-01-18 US US08/184,759 patent/US5679785A/en not_active Expired - Fee Related
-
1995
- 1995-06-01 US US08/456,734 patent/US5668269A/en not_active Expired - Fee Related
- 1995-06-01 US US08/457,377 patent/US5659025A/en not_active Expired - Fee Related
-
1996
- 1996-09-13 GR GR960402400T patent/GR3021041T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920012107A (ko) | 3'-(2')-아미노- 또는 티올-변형되고 형광 염료-결합된 뉴클레오사이드, 뉴클레오타이드 및 올리고뉴클레오타이드, 및 이의 제조방법 및 용도 | |
JP3514679B2 (ja) | ポリヌクレオチド配列検出のための改変されたプライマー伸長反応 | |
EP0637314A1 (en) | N-acylated 2'-deoxycytidines useful in oligonucleotide synthesis | |
BR0114227A (pt) | Poliuretanos curáveis, revestimentos feitos dos mesmos e método para fazê-los | |
PT693065E (pt) | Derivados de cumarina nao-nucleosidicos como agentes reticulantes de polionucleotidos | |
EP0233053A2 (en) | Method of detecting electrophoretically separated oligonucleotides | |
CA2924186A1 (en) | Highly efficient synthesis of long rna using reverse direction approach | |
KR880012631A (ko) | 데스아자푸린- 누클레오시드 유도체, 이들의 제조방법, 이들을 함유하는 제학적 조성물, 헥산 배열을 위한 이들의 용도 그리고 안티바이러스제로서 이들의 용도 | |
BR9908245A (pt) | Composição geradora de gás, e, processo de formação de um gerador de gás de não-azida de alto rendimento de gás e de taxa de queima aumentada | |
AU8181201A (en) | Immunostimulatory oligodeoxynucleotides | |
DE59510252D1 (de) | Polyamid-Oligonucleotid-Derivate, deren Herstellung und Verwendung | |
DE59601683D1 (de) | Sulfamat-derivate von 1,3,5(10)-estratrien-derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
ATE20895T1 (de) | Beta-d-galactosederivate, verfahren zu ihrer herstellung und ihre verwendung. | |
Ohtsuka et al. | Synthesis of protected ribooligonucleotides with 3'-phosphate end groups | |
ATE39698T1 (de) | Verfahren zur herstellung von oligonucleosidphosphonaten. | |
WO1994012518A3 (de) | Reagenz zur kupplung veschiedener substanzen an nukleinsäuren sowie verfahren zu dessen herstellung | |
FR2835836B1 (fr) | Metallocenes bifonctionnalises, procede d'obtention, utilisation pour le marquage de molecules biologiques | |
DE50302339D1 (de) | Wasserlösliche faserreaktive farbstoffe, verfahren zu ihrer herstellung und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |